DRCT: the cashflow

MyFinsight

For the quarter ending 2025-09-30, DRCT had -$722K decrease in cash & cash equivalents over the period.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-15,136	-
Amortization of deferred financing cost and debt discount (premium), net	223	2,900
Amortization of intangible assets	488	977
Reduction in carrying amount of right-of-use assets	45	90
Depreciation and amortization of property, equipment and software	70	145
Stock-based compensation	374	705
Deferred income taxes	0	0
Derecognition of tax receivable agreement liability	0	-
Provision for credit losses/bad debt expense	6	0
Accounts receivable	-291	-1,082
Prepaid expenses and other assets	36	842
Accounts payable	2,130	-1,491
Accrued liabilities and tax receivable agreement payable	16	962
Income taxes payable	25	41
Deferred revenues	-22	63
Operating lease liability	-50	-92
Net cash used in operating activities	-1,638	-5,398
Cash paid for capitalized software and property and equipment	0	38
Net cash used in investing activities	0	-38
Proceeds from note payable	3,804	-
Payments on term loan	0	0
Proceeds from line of credit	0	0
Payments on shares withheld for taxes	0	0
Payment of expenses for equity reserve facility	0	198
Payment of deferred financing cost	-	46
Proceeds from issuance of class a common stock	766	5,942
Payments on financed insurance premiums	0	114
Payments on line of credit	3,700	-
Proceeds from options exercised	0	0
Proceeds from warrants exercised	0	0
Net cash provided by financing activities	916	5,584
Net decrease in cash and cash equivalents	-722	148
Cash and cash equivalents at beginning of period	1,445	-
Cash and cash equivalents at end of period	871	-

Unit: Thousand (K) dollars